Deal Detail

TheraBreath to Church & Dwight

EV / LTM EBITDA

21.5x

EV / LTM Sales

6.7x

Enterprise Value

$580M

Primary Source

Company Release

All Observations

Source-specific multiples and notes for this transaction.

Primary?	Source Type	Fairness Opinion / Source	Advisor	Source Year	Enterprise Value	EV/Sales	EV/EBITDA	EV/Fwd EBITDA	Note	Citation
Primary	press release	Press Release	-	2021	$580M	6.7x	21.5x	-	18.7x LTM and 13.7x fwd Net of $85m tax shield, the deal is a $495 million acquisition (based on $36MM of 2022 run rate EBITDA).	Open